Stock Comparison
Agilent Technologies, Inc. vs Roche Holding AG
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Agilent Technologies, Inc.
A · New York Stock Exchange
Weighted across the company's segments.
Full stock profile
Dive deeper into Agilent Technologies, Inc.'s moat claims, evidence, and risks.
View A analysisRoche Holding AG
ROP · SIX Swiss Exchange (participation certificate)
Weighted across the company's segments.
Full stock profile
Dive deeper into Roche Holding AG's moat claims, evidence, and risks.
View ROP analysisComparison highlights
- Moat score gap: Roche Holding AG leads (69 / 100 vs 63 / 100 for Agilent Technologies, Inc.).
- Segment focus: Agilent Technologies, Inc. has 3 segments (41.9% in Agilent CrossLab); Roche Holding AG has 2 segments (77.8% in Pharmaceuticals).
- Moat breadth: Agilent Technologies, Inc. has 4 moat types across 2 domains; Roche Holding AG has 3 across 2.
Primary market context
Agilent Technologies, Inc.
Agilent CrossLab
Laboratory services, compliance/maintenance, consumables and lab informatics across the lab workflow
Global
B2B (installed base labs across pharma, diagnostics, academia and applied markets)
Aftermarket services + consumables + informatics
41.9%
Roche Holding AG
Pharmaceuticals
Innovative (branded) prescription pharmaceuticals
Global
Healthcare providers and systems (hospitals/clinics), payers/governments, and patients
Innovator pharmaceutical developer, manufacturer and marketer
77.8%
Side-by-side metrics
Moat coverage
Shared moat types
Agilent Technologies, Inc. strengths
Roche Holding AG strengths
Segment mix
Agilent Technologies, Inc. segments
Full profile >Life Sciences and Diagnostics Markets
Competitive
Agilent CrossLab
Competitive
Applied Markets
Oligopoly
Roche Holding AG segments
Full profile >Pharmaceuticals
Competitive
Diagnostics
Oligopoly
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.